Hans‐Karl Heim
- Immunology top 10%
- Economics and Econometrics top 10%
- Pediatrics, Perinatology and Child Health
- Oncology
- Genetics
- Co-authors
- Martina WeiseLeon van AertsEsa HeinonenIordanis GravanisFalk EhmannCamille VleminckxGabriele ReichmannNiklas Ekman
- Topics
- Antiplatelet Therapy and Cardiovascular Diseases (3 papers)Inflammatory mediators and NSAID effects (3 papers)Proteoglycans and glycosaminoglycans research (2 papers)
- Journals
- BloodBritish Journal of PharmacologyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Partner nations
- GermanyNetherlandsDenmark
In The Last Decade
Hans‐Karl Heim
13 papers receiving 342 citations
Peers
Comparison fields: 5 of 71
- Immunology 248
- Economics and Econometrics 103
- Pediatrics, Perinatology and Child Health 79
- Oncology 78
- Genetics 48
Countries citing papers authored by Hans‐Karl Heim
This map shows the geographic impact of Hans‐Karl Heim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Karl Heim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Karl Heim more than expected).
Fields of papers citing papers by Hans‐Karl Heim
This network shows the impact of papers produced by Hans‐Karl Heim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Karl Heim. The network helps show where Hans‐Karl Heim may publish in the future.
Co-authorship network of co-authors of Hans‐Karl Heim
This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Karl Heim. A scholar is included among the top collaborators of Hans‐Karl Heim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Karl Heim. Hans‐Karl Heim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 261 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 22 | |
| 5 | 8 | |
| 6 | 8 | |
| 7 | 18 | |
| 8 | 11 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 9 |
About Hans‐Karl Heim
Hans‐Karl Heim is a scholar working on Cell Biology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 13 papers that have together received 363 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Proteoglycans and glycosaminoglycans research (2 papers). The work is most often cited by research in Immunology (248 citations), Pediatrics, Perinatology and Child Health (79 citations) and Economics and Econometrics (103 citations). Hans‐Karl Heim has collaborated with scholars based in Germany, Netherlands and Denmark. Frequent co-authors include Martina Weise, Leon van Aerts, Esa Heinonen, Iordanis Gravanis, Falk Ehmann, Camille Vleminckx, Gabriele Reichmann, Niklas Ekman, Robin Thorpe and Christian K. Schneider. Their work appears in journals such as Blood, British Journal of Pharmacology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.